vimarsana.com
Home
Live Updates
FDA Approves Amgen's WEZLANA As Biosimilar to and Interchang
FDA Approves Amgen's WEZLANA As Biosimilar to and Interchang
FDA Approves Amgen's WEZLANA As Biosimilar to and Interchangeable With Janssen's STELARA (ustekinumab) | Goodwin
On Tuesday, October 31, FDA approved Amgen’s WEZLANA (ustekinumab-auub) as biosimilar to and interchangeable with Janssen’s STELARA (ustekinumab). WEZLANA is the first product to be...
Related Keywords
Texas ,
United States ,
,
Global Colon Cancer Association ,
Inflation Reduction Act Drug Price Negotiation Program ,
Drug Price Negotiation Program ,
Amgen ,
National Infusion Center Association ,
Inflation Reduction Act ,
Drug Price Negotiation ,
Price Negotiations ,
Western District ,
Last Thursday ,